Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Arecor Therape Share Price
  4. Arecor Therape Share Regulatory News

Pin to quick picksArecor Therape Regulatory News (AREC)

Arecor Therape Information

Share Price Information for Arecor Therape (AREC)

Share Price is delayed by 15 minutes
Get Live Data
66.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 8.00 (12.903%)
Market Cap: £24.92m
AREC Live PriceLast checked at - London Stock Exchange

Intraday Arecor Therape Share Chart

1234
Date   Source Headline
22nd Mar 20237:00 amRNSFIRST PATIENT DOSED IN AT278 CLINICAL TRIAL
13th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20232:05 pmRNSSecond Price Monitoring Extn
13th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 202311:05 amRNSSecond Price Monitoring Extn
13th Mar 202311:00 amRNSPrice Monitoring Extension
13th Mar 20239:05 amRNSSecond Price Monitoring Extn
13th Mar 20239:00 amRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSARECOR TO PRESENT SHARESOC WEBINAR
24th Feb 20234:44 pmRNSHolding(s) in Company
24th Feb 20237:00 amRNSNotice of Results
16th Feb 20237:00 amRNSArecor Granted Patents in India and the US
14th Feb 20237:01 amRNSARECOR STRENGTHENS COLLABORATION WITH PARTNER
30th Jan 20237:00 amRNSArecor Publishes Data for AT278 in Diabetes Care
19th Jan 20237:00 amRNSBUSINESS UPDATE
12th Jan 20237:00 amRNSARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA
4th Jan 20237:00 amRNSTETRIS PHARMA LAUNCHES OGLUO® IN AUSTRIA
12th Dec 202210:04 amRNSTETRIS PHARMA SERVICE AGREEMENT WITH SYNEOS HEALTH
6th Dec 20224:03 pmRNSGrant of LTIP Options and PDMR Dealing
22nd Nov 20227:00 amRNSARECOGRANTED PATENT IN JAPAN AND SOUTH KOREA
22nd Nov 20227:00 amRNSARECOR TO COMMENCE SECOND TRIAL WITH AT278
17th Nov 20227:00 amRNSGrant of AESOP Options and PDMR Dealing
15th Nov 202212:44 pmEQSArecor Therapeutics scientist hopeful that artificial pancreas 'edging closer'
10th Nov 20227:00 amRNSSPECIALTY HOSPITAL FORMULATION COLLABORATION
8th Nov 20227:00 amRNSExercise of options and PDMR dealing
1st Nov 20227:00 amRNSTETRIS PHARMA LAUNCHES OGLUO® IN GERMANY
11th Oct 20227:00 amRNSHeadline results from Phase I trial of AT247
20th Sep 202211:03 amRNSArecor Presents Positive Data for AT278 at EASD
8th Sep 20227:00 amRNSInterim Results for six months ended 30 June 2022
17th Aug 20227:00 amRNSNotice of Interim Results
9th Aug 20227:00 amRNSARECOR GRANTED EUROPEAN PATENTS
5th Aug 20223:33 pmRNSHolding(s) in Company
5th Aug 202211:52 amRNSHolding(s) in Company
4th Aug 20222:09 pmRNSHolding(s) in Company
4th Aug 20222:08 pmRNSHolding(s) in Company
4th Aug 202210:45 amRNSHolding(s) in Company
4th Aug 20228:55 amRNSDirector/PDMR Dealings
2nd Aug 20224:52 pmRNSArecor on Investor Meet Company Platform
1st Aug 20222:46 pmRNSResult of Placing
1st Aug 20227:00 amRNSProposed Acquisition of Tetris Pharma Ltd
14th Jul 20227:00 amRNSBUSINESS UPDATE
4th Jul 20227:00 amRNSARECOR ANNOUNCES PRESENTATION AT EASD 2022
16th Jun 20227:00 amRNSARECOR COLLABORATES WITH TOP GLOBAL PHARMA COMPANY
23rd May 20222:19 pmRNSRESULT OF AGM
23rd May 20227:00 amRNSArecor AGM statement
18th May 20228:00 amRNSARECOR TO HOST KOL WEBINAR
28th Apr 20227:00 amRNSARECOR PRESENTS AT278 PHASE I DATA AT ATTD MEETING
27th Apr 20225:08 pmRNSARECOR 2021 ANNUAL REPORT AND NOTICE OF AGM
27th Apr 20227:00 amRNSArecor on Investor Meet Company Platform
25th Apr 20227:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
1234

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
IPE
IPE.L
LSE
0.00%
INPP
International Public Partnerships
LSE
0.00%
AAS
Aberdeen Asia
LSE
0.00%
PCT
Polar Capital Technology Trust
LSE
0.00%
SRES
Sunrise Resources PLC
LSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
0.00%
LLOY
Lloyds
LSE
0.00%
GGP
Greatland Resources
LSE
0.00%
GST
GSTechnologies
LSE
0.00%
HE1
Helium One
LSE
0.00%